Clinical Trial: A Study of JNJ-87890387 for Advanced Solid Tumors
Study Status: Completed
Recruit Status: RECRUITING
Condition: Advanced Solid Tumors
Study Type: INTERVENTIONAL
Official Title: A Phase 1 Study of JNJ-87890387, an Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 3 (ENPP3) x CD3 Bispecific Antibody, for Advanced Solid Tumors
Brief Summary:
The purpose of this study is to determine recommended phase 2 dose(s) (RP2Ds) of JNJ-87890387 and to determine the safety of JNJ-87890387 at the RP2D(s).
Read more